66(6): 81825 Niemi M, Backman JT, Kajosaari LI, et al
The Precision Peptide Genetic Test reveals predispositions in key GLP-1 pathway variantsincluding GIPR rs1800437that relate to how your body's GLP-1 signaling responds to consistent drug dosing and timing
If you relate to any of the following, you may be a candidate for GLP-1 Agonist: BMI over 27 (or over 25 with an obesity-related condition like diabetes or high blood pressure) Previous difficulty losing and keeping weight off with diet, exercise, and/or other medications Ready for an extra push to boost your weight loss results Wanting to improve your health by losing excess body weight Our medical providers will thoroughly assess your health profile during a consultation to determine if GLP-1 Agonist is appropriate for your needs and goals
Older patients are more susceptible to dehydration from gastrointestinal side effects and may have reduced thirst perception
Oral contraceptives may be less effective during dose escalation, so barrier contraception is recommended for 30 days after start and after any dose change
This can be prevented by: Rotating injection locations Cleaning the vial and injection site with a 70% isopropyl alcohol swab Below are several contraindications that should be considered before administering BPC-157